Search company, investor...

Predict your next investment

Venture Capital
chv.vc

Investments

67

Portfolio Exits

11

Funds

7

About Catalyst Health Ventures

Catalyst Health Ventures is an early-stage venture capital firm that invests in the healthcare sector.

Headquarters Location

50 Braintree Hill Office Park Suite 301

Braintree, Massachusetts, 02184,

United States

781-228-5228

Want to inform investors similar to Catalyst Health Ventures about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Research containing Catalyst Health Ventures

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Catalyst Health Ventures in 1 CB Insights research brief, most recently on May 12, 2021.

Latest Catalyst Health Ventures News

Rejoni Raises $25M in Series B Funding for Its Hydrogel System to Prevent Intrauterine Adhesions Following Transcervical Gynecological Procedures

Dec 13, 2022

Medtech company Rejoni has raised $25M in Series B funding from Catalyst Health Ventures. Other investors in the round include Ascension Health Ventures, Delos Capital, Sparta Group, Amed Ventures, and Iyengar Capital Partners. Rejoni raised its $15M Series A in September 2020. Rejoni is a privately held medical technology company designing and developing hydrogels to improve the standard of care in Women’s Health. Rejoni’s…

Catalyst Health Ventures Investments

67 Investments

Catalyst Health Ventures has made 67 investments. Their latest investment was in PanTher Therapeutics as part of their Series B on December 12, 2022.

CBI Logo

Catalyst Health Ventures Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

12/19/2022

Series B

PanTher Therapeutics

$1.26M

No

Catalyst Health Ventures, and Undisclosed Investors

1

12/7/2022

Series B

Rejoni

$25M

Yes

6

7/18/2022

Unattributed VC

Aria CV

$7.77M

No

1

3/11/2022

Series A

Subscribe to see more

$99M

Subscribe to see more

10

2/17/2022

Series B

Subscribe to see more

$99M

Subscribe to see more

10

Date

12/19/2022

12/7/2022

7/18/2022

3/11/2022

2/17/2022

Round

Series B

Series B

Unattributed VC

Series A

Series B

Company

PanTher Therapeutics

Rejoni

Aria CV

Subscribe to see more

Subscribe to see more

Amount

$1.26M

$25M

$7.77M

$99M

$99M

New?

No

Yes

No

Subscribe to see more

Subscribe to see more

Co-Investors

Catalyst Health Ventures, and Undisclosed Investors

Sources

1

6

1

10

10

Catalyst Health Ventures Portfolio Exits

11 Portfolio Exits

Catalyst Health Ventures has 11 portfolio exits. Their latest portfolio exit was Sera Prognostics on July 16, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

7/16/2021

IPO

$99M

Public

1

9/3/2020

Acquired

$99M

12

9/6/2018

Acquired

$99M

5

6/4/2018

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

4/16/2018

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

7/16/2021

9/3/2020

9/6/2018

6/4/2018

4/16/2018

Exit

IPO

Acquired

Acquired

Acquired

Acquired

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Public

Subscribe to see more

Subscribe to see more

Sources

1

12

5

10

10

Catalyst Health Ventures Fund History

7 Fund Histories

Catalyst Health Ventures has 7 funds, including CHV SPV I.

Closing Date

Fund

Fund Type

Status

Amount

Sources

12/22/2020

CHV SPV I

$1.05M

1

12/18/2020

Catalyst Health Ventures IV

$99M

10

12/18/2020

CHV Partners Fund IV

$99M

10

7/18/2016

Catalyst Health Ventures Follow-On Fund

Subscribe to see more

Subscribe to see more

$99M

10

12/31/2012

Catalyst Health Ventures III LP

Subscribe to see more

Subscribe to see more

10

Closing Date

12/22/2020

12/18/2020

12/18/2020

7/18/2016

12/31/2012

Fund

CHV SPV I

Catalyst Health Ventures IV

CHV Partners Fund IV

Catalyst Health Ventures Follow-On Fund

Catalyst Health Ventures III LP

Fund Type

Subscribe to see more

Subscribe to see more

Status

Subscribe to see more

Subscribe to see more

Amount

$1.05M

$99M

$99M

$99M

Sources

1

10

10

10

10

Catalyst Health Ventures Team

5 Team Members

Catalyst Health Ventures has 5 team members, including current Chief Executive Officer, Nick Kimball.

Name

Work History

Title

Status

Nick Kimball

Chief Executive Officer

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Nick Kimball

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Work History

Title

Chief Executive Officer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.